Prestige Consumer Healthcare Inc. (PBH) [Rocket]

In millions, except per share items	Mar-31-22	Mar-31-21	Mar-31-20	Mar-31-19	Mar-05-19	Mar-31-18	Mar-31-17	Mar-31-16
	10-K	10-K	10-K	10-K	8-K	10-K	10-K	10-K
Revenues:
North American OTC Healthcare	967.9	849.3	859.4	862.4		868.9	720.8	657.9
Supplier Concentration Risk	749.9	665.1
International OTC Healthcare	118.9	94.0	103.6	93.5		91.7	73.3	57.7
Intersegment Eliminations	3.0	3.2	3.5	7.4
Other				12.4		80.6	87.9	90.7
Total revenues [+]	1,086.8	943.4	963.0	975.8	975.8	1,041.2	882.1	806.2
Products					975.7			803.1
Other					0.1			3.2
Revenue growth [+]	15.2%	-2.0%	-1.3%	-6.3%		18.0%	9.4%	12.8%
North American OTC Healthcare	14.0%	-1.2%	-0.4%	-0.7%		20.5%	9.6%	16.0%
Supplier Concentration Risk	12.8%
International OTC Healthcare	26.5%	-9.3%	10.8%	2.0%		25.0%	27.0%	-0.1%
Intersegment Eliminations	-6.3%	-8.6%	-52.7%
Cost of goods sold	466.2	395.9	410.8	420.2	420.2	464.7	381.8	339.0
Gross profit	620.6	547.5	552.2	555.6	555.6	576.5	500.3	467.2
Gross margin	57.1%	58.0%	57.3%	56.9%	56.9%	55.4%	56.7%	57.9%
Selling, general and administrative [+]	265.9	226.1	236.3	232.8	232.8	232.7	217.5	183.2
Sales and marketing	157.3	140.6	147.2	143.1	143.1	147.3	128.4	110.8
General and administrative	108.5	85.5	89.1	89.8	89.8	85.4	89.1	72.4
Other operating expenses					27.0
EBITDA [+]	362.0	327.6	320.2	327.5	327.5	348.8	283.3	284.0
EBITDA growth	10.5%	2.3%	-2.2%	-6.1%		23.1%	-0.3%	26.7%
EBITDA margin	33.3%	34.7%	33.2%	33.6%	33.6%	33.5%	32.1%	35.2%
Depreciation	10.6	10.6	29.0	31.8	31.8	33.4	25.8	23.7
EBITA	351.4	317.0	291.2	295.7	295.7	315.4	257.5	260.3
EBITA margin	32.3%	33.6%	30.2%	30.3%	30.3%	30.3%	29.2%	32.3%
Amortization of intangibles	21.5	19.6
EBIT [+]	329.9	297.4	291.2	295.7	295.7	315.4	257.5	260.3
EBIT growth	10.9%	2.1%	-1.5%	-6.3%		22.5%	-1.1%	26.1%
EBIT margin	30.4%	31.5%	30.2%	30.3%	30.3%	30.3%	29.2%	32.3%
Non-recurring items [+]				228.2	228.2	99.9	51.8
Asset impairment				229.5	229.5	99.9
Loss (gain) on sale of assets					-1.3
Loss (gain) on disposal of assets				-1.3			51.8
Interest expense, net [+]	64.3	82.3	96.2	105.1	-0.2	105.9	93.3	85.2
Interest expense	64.3	82.3	96.2	105.1		106.3	93.5	85.3
Interest income					0.2	0.4	0.2	0.2
Other income (expense), net [+]	-3.2	-11.0	-3.8	-0.5	-105.8	-2.5	-1.5	-18.0
Gain (loss) on debt retirement	-2.1	-12.3	-2.2			-2.9	-1.4	-18.0
Pre-tax income	262.5	204.1	191.2	-38.1	-38.1	107.1	110.9	157.2
Income taxes	57.1	39.4	48.9	-2.3	-2.3	-232.5	41.5	57.3
Tax rate	21.7%	19.3%	25.6%	5.9%	5.9%		37.4%	36.4%
Net income	205.4	164.7	142.3	-35.8	-35.8	339.6	69.4	99.9
Net margin	18.9%	17.5%	14.8%	-3.7%	-3.7%	32.6%	7.9%	12.4%

Basic EPS [+]	$4.09	$3.28	$2.81	($0.69)	($0.69)	$6.40	$1.31	$1.89
Growth	24.6%	16.9%	-508.0%	-110.8%		388.2%	-30.8%	26.2%
Diluted EPS [+]	$4.04	$3.25	$2.78	($0.69)	($0.69)	$6.34	$1.30	$1.88
Growth	24.1%	17.0%	-504.6%	-110.8%		387.8%	-30.8%	26.5%

Shares outstanding (basic) [+]	50.3	50.2	50.7	52.1	52.1	53.1	53.0	52.8
Growth	0.1%	-1.0%	-2.6%	-1.9%		0.2%	0.4%	1.1%
Shares outstanding (diluted) [+]	50.8	50.6	51.1	52.1	52.1	53.5	53.4	53.1
Growth	0.5%	-1.0%	-1.8%	-2.7%		0.3%	0.4%	0.9%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.